Curis | CRIS - Equity Capital And Reserves


Curis reported $12.71M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 1.29M 865K Mar/2026
Amgen USD 11.69B 2.5B Jun/2026
AstraZeneca USD 50.3B 2.96B Jun/2026
Bayer EUR 29.71B 863M Jun/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
CSL USD 18.66B 2.75B Dec/2025
Curis USD 12.71M 7.24M Mar/2026
Eli Lilly USD 33.88B 2.68B Jun/2026
Exelixis USD 1.84B 91.99M Jun/2026
Gilead Sciences USD 11.74B 11.77B Jun/2026
GlaxoSmithKline GBP 17.64B 223M Jun/2026
Incyte USD 6.34B 721.58M Jun/2026
Merck USD 41.93B 3.94B Jun/2026
Novartis USD 41.95B 3.02B Jun/2026
Pfizer USD 85.19B 4.91B Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sanofi EUR 69.57B 3.24B Jun/2026
Takeda JPY 7.56T 215.7B Jun/2026
TG Therapeutics USD 604.08M 20.95M Jun/2026
Verastem USD 81.78M 24.58M Mar/2026